Les Tillack, Chief Executive Officer, Luina Bio, Australia
What are the key highlights of the kit being developed with XING Technologies?
The new diagnostic kit is an antigen test. This new test directly measures the presence of the SARS-CoV-2 virus proteins. A positive antigen test is considered very accurate and can be manufactured cheaper as a lowcost point-of-care diagnostic on lateral flow device. This test does not measure the antibody response. Antibody or serology tests do not pick up infectious patients, as it takes 7 to 14 days for an antibody response against the virus. This test also does not impact the traditional antibody supply chain and is rapidly scalable to distribution.
By when would this test be available in the market? Would it be economical?
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE